No problem.
The idea that the hallucinogenic effects of DXM are separate from its dissociative effects probably comes from the days during which DXM was practically the only dissociative any active drug user had tried, thus making it far harder to understand, compounded further by the lack of scientific research in that area. No current information I have stumbled upon nor any experiences I have had would suggest that there is any separation; DXO seems likely to produce most of the dissociative effects of DXM, and therefore it likely produces most of the hallucinogenic effects as well.
Ketamine-like dissociatives
are "psychedelic" in nature. There are several studies such as
this recent one which show that ketamine and other dissociatives have broadly comparable effects to psychedelics on brain activity, from electrical activity, to metabolic hyperfrontality, to cortical pyramidal neuron excitation, and so on. Speaking from personal experience with a handful of dissociatives (DXM, nitrous oxide, memantine, ketamine, methoxetamine, 2'-Oxo-PCE) I can also say that they all produce varying psychedelic-like effects, including hallucinations and ego loss and creative analytical states and so on. They also produce effects that are not psychedelic, like alcohol-like visual disturbances and disinhibition, but those differences don't detract from the similarities.
DXM and DXO are both NMDA receptor antagonists, so they may both contribute some dissociative-psychedelic effects, especially with very high dosages, but largely, given that DXM readily metabolizes into DXO and DXO is much more potent as a NMDA receptor antagonist, it is again likely pretty much all the DXO producing the effects most of the time. DXM itself doesn't seem to add much to the experience from what I've seen so far.